154 related articles for article (PubMed ID: 28011209)
1. Validation of Clinical Tools for Vaginal and Vulvar Symptom Assessment in Cancer Patients and Survivors.
Eaton AA; Baser RE; Seidel B; Stabile C; Canty JP; Goldfrank DJ; Carter J
J Sex Med; 2017 Jan; 14(1):144-151. PubMed ID: 28011209
[TBL] [Abstract][Full Text] [Related]
2. Vaginal and sexual health treatment strategies within a female sexual medicine program for cancer patients and survivors.
Carter J; Stabile C; Seidel B; Baser RE; Goldfarb S; Goldfrank DJ
J Cancer Surviv; 2017 Apr; 11(2):274-283. PubMed ID: 27868156
[TBL] [Abstract][Full Text] [Related]
3. A single-arm clinical trial investigating the effectiveness of a non-hormonal, hyaluronic acid-based vaginal moisturizer in endometrial cancer survivors.
Carter J; Goldfarb S; Baser RE; Goldfrank DJ; Seidel B; Milli L; Saban S; Stabile C; Canty J; Gardner GJ; Jewell EL; Sonoda Y; Kollmeier MA; Alektiar KM
Gynecol Oncol; 2020 Aug; 158(2):366-374. PubMed ID: 32522420
[TBL] [Abstract][Full Text] [Related]
4. A single-arm, prospective trial investigating the effectiveness of a non-hormonal vaginal moisturizer containing hyaluronic acid in postmenopausal cancer survivors.
Carter J; Baser RE; Goldfrank DJ; Seidel B; Milli L; Stabile C; Canty J; Saban S; Goldfarb S; Dickler MN; Gardner GJ; Jewell EL; Sonoda Y; Kollmeier MA; Alektiar KM
Support Care Cancer; 2021 Jan; 29(1):311-322. PubMed ID: 32358778
[TBL] [Abstract][Full Text] [Related]
5. Convergent-Divergent Validity and Correlates of the Day-to-Day Impact of Vaginal Aging Domain Scales in the MsFLASH Vaginal Health Trial.
Hunter MM; Guthrie KA; Larson JC; Reed SD; Mitchell CM; Diem SJ; LaCroix AZ; Huang AJ
J Sex Med; 2020 Jan; 17(1):117-125. PubMed ID: 31812686
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of hypnosis for the treatment of vulvar vestibulitis syndrome: a preliminary investigation.
Pukall C; Kandyba K; Amsel R; Khalifé S; Binik Y
J Sex Med; 2007 Mar; 4(2):417-25. PubMed ID: 17367437
[TBL] [Abstract][Full Text] [Related]
7. Baseline characteristics and concerns of female cancer patients/survivors seeking treatment at a Female Sexual Medicine Program.
Carter J; Stabile C; Seidel B; Baser RE; Gunn AR; Chi S; Steed RF; Goldfarb S; Goldfrank DJ
Support Care Cancer; 2015 Aug; 23(8):2255-65. PubMed ID: 25567673
[TBL] [Abstract][Full Text] [Related]
8. Patient interest in the Lowdown on Down There: attendance at a vulvovaginal and sexual health workshop post-cancer treatment.
Millman R; Jacox N; Sears C; Robinson JW; Turner J; Walker LM
Support Care Cancer; 2020 Aug; 28(8):3889-3896. PubMed ID: 31845008
[TBL] [Abstract][Full Text] [Related]
9. Long-term results of an individualized, multifaceted, and multidisciplinary therapeutic approach to provoked vestibulodynia.
Spoelstra SK; Dijkstra JR; van Driel MF; Weijmar Schultz WC
J Sex Med; 2011 Feb; 8(2):489-96. PubMed ID: 20646179
[TBL] [Abstract][Full Text] [Related]
10. Assessment of vulvar discomfort with sexual activity among women in the United States.
Flynn KE; Carter J; Lin L; Lindau ST; Jeffery DD; Reese JB; Schlosser BJ; Weinfurt KP
Am J Obstet Gynecol; 2017 Apr; 216(4):391.e1-391.e8. PubMed ID: 27988269
[TBL] [Abstract][Full Text] [Related]
11. Assessing sexual function and dyspareunia with the Female Sexual Function Index (FSFI) in women with vulvodynia.
Masheb RM; Lozano-Blanco C; Kohorn EI; Minkin MJ; Kerns RD
J Sex Marital Ther; 2004; 30(5):315-24. PubMed ID: 15672599
[TBL] [Abstract][Full Text] [Related]
12. Relationship between changes in vulvar-vaginal atrophy and changes in sexual functioning.
Pinkerton JV; Bushmakin AG; Komm BS; Abraham L
Maturitas; 2017 Jun; 100():57-63. PubMed ID: 28539177
[TBL] [Abstract][Full Text] [Related]
13. The REVIVE (REal Women's VIews of Treatment Options for Menopausal Vaginal ChangEs) survey in Europe: Country-specific comparisons of postmenopausal women's perceptions, experiences and needs.
Nappi RE; Palacios S; Particco M; Panay N
Maturitas; 2016 Sep; 91():81-90. PubMed ID: 27451325
[TBL] [Abstract][Full Text] [Related]
14. Measuring symptom relief in studies of vaginal and vulvar atrophy: the most bothersome symptom approach.
Ettinger B; Hait H; Reape KZ; Shu H
Menopause; 2008; 15(5):885-9. PubMed ID: 18779677
[TBL] [Abstract][Full Text] [Related]
15. Vulvovaginal symptoms prevalence in postmenopausal women and relationship to other menopausal symptoms and pelvic floor disorders.
Erekson EA; Li FY; Martin DK; Fried TR
Menopause; 2016 Apr; 23(4):368-75. PubMed ID: 26645820
[TBL] [Abstract][Full Text] [Related]
16. Technological evolution in the radiofrequency treatment of vaginal laxity and menopausal vulvo-vaginal atrophy and other genitourinary symptoms: first experiences with a novel dynamic quadripolar device.
Vicariotto F; Raichi M
Minerva Ginecol; 2016 Jun; 68(3):225-36. PubMed ID: 27206062
[TBL] [Abstract][Full Text] [Related]
17. The Women's EMPOWER Survey: Women's Knowledge and Awareness of Treatment Options for Vulvar and Vaginal Atrophy Remains Inadequate.
Krychman M; Graham S; Bernick B; Mirkin S; Kingsberg SA
J Sex Med; 2017 Mar; 14(3):425-433. PubMed ID: 28202319
[TBL] [Abstract][Full Text] [Related]
18. Validation of a Women's Sexual Interest Diagnostic Interview--Short Form (WSID-SF) and a Daily Log of Sexual Activities (DLSA) in postmenopausal women with hypoactive sexual desire disorder.
DeRogatis LR; Allgood A; Auerbach P; Eubank D; Greist J; Bharmal M; Zipfel L; Guo CY
J Sex Med; 2010 Feb; 7(2 Pt 2):917-27. PubMed ID: 19832932
[TBL] [Abstract][Full Text] [Related]
19. Presenting symptoms among premenopausal and postmenopausal women with vulvodynia: a case series.
Phillips NA; Brown C; Foster D; Bachour C; Rawlinson L; Wan J; Bachmann G
Menopause; 2015 Dec; 22(12):1296-300. PubMed ID: 26325083
[TBL] [Abstract][Full Text] [Related]
20. Dynamic quadripolar radiofrequency treatment of vaginal laxity/menopausal vulvo-vaginal atrophy: 12-month efficacy and safety.
Vicariotto F; DE Seta F; Faoro V; Raichi M
Minerva Ginecol; 2017 Aug; 69(4):342-349. PubMed ID: 28608667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
